Ghrelin axis reveals the interacting influence of central obesity and hypertension
Ghrelin axis reveals the interacting influence of central obesity and hypertension
Objective: This study aimed to investigate how central obesity and hypertension modulate unacylated ghrelin (UnAG), acylated ghrelin (AG), obestatin, growth hormone (GH), and the ratios of UnAG/obestatin, AG/obestatin, and total ghrelin/obestatin. Methods: Circulatory abundances of UnAG, AG, obestatin and GH were determined in 387 Hong Kong Chinese female adults with age between 24 to 86 years based on a 2 × 2 factorial design of hypertension (blood pressure ≥140/90 mmHg) and central obesity (waist circumference or WC ≥80 cm). Participants were categorized as neither hypertensive nor centrally obese (NHNO; n = 105), hypertensive but not centrally obese (HNO; n = 102), centrally obese but not hypertensive (NHO; n = 74) and hypertensive and centrally obese (NO; n = 106). Pearson's correlation analyses were performed to detect the association between the peptides examined with WC and blood pressure. The main and interaction effects of hypertension and central obesity were examined by generalized estimating equations analyses. Results: Correlation analyses revealed that systolic blood pressure was negatively correlated with AG/obestatin, UnAG/obestatin and total ghrelin/obestatin ratios, AG, total ghrelin, and GH, while diastolic blood pressure was negatively correlated with UnAG/obestatin, total ghrelin/obestatin ratios, and GH. WC was negatively correlated with AG/obestatin, UnAG/obestatin, and total ghrelin/obestatin ratios, UnAG, AG, total ghrelin, GH, and obestatin. Interaction effects of hypertension and central obesity were observed on UnAG/obestatin, AG/obestatin and total ghrelin/obestatin ratios, and obestatin. Obestatin in NHO group was significantly higher compared to NHNO and HO groups. UnAG/obestatin, AG/obestatin, and total ghrelin/obestatin ratios were higher in NHNO group compared to HNO and HO groups. Main effects of central obesity and hypertension were observed in UnAG, total ghrelin and GH. The HO group manifested the lowest level of UnAG, total ghrelin and GH among all the groups studied. Main effect of hypertension was observed on AG, suggesting that hypertensive individuals exhibited lower levels of AG regardless of central obesity. Conclusion: Circulatory ghrelin gene products and GH exhibit different modes of modulation in response to the co-manifestation of multiple cardiovascular risk factors compared with a single risk factor alone.
Central obesity, Ghrelin, Growth hormone, Hypertension, Obestatin
Yu, Angus P.
e9174c18-c499-460e-922f-eef235c51319
Ugwu, Felix N.
54edddba-b314-4631-b93a-c1d44c61f7b5
Tam, Bjorn T.
d48d482e-0316-49ec-bfd2-d46e48789e7e
Lee, Paul H.
02620eab-ae7f-4a1c-bad1-8a50e7e48951
Lai, Christopher W.
83f3d235-4de6-4462-b3d9-22c377e86afd
Wong, Cesar S.C.
5566017b-ca80-4a87-9d11-4e072e390085
Siu, Parco M.
3a92bd40-810f-44e8-80d3-585b634d0bf6
12 September 2018
Yu, Angus P.
e9174c18-c499-460e-922f-eef235c51319
Ugwu, Felix N.
54edddba-b314-4631-b93a-c1d44c61f7b5
Tam, Bjorn T.
d48d482e-0316-49ec-bfd2-d46e48789e7e
Lee, Paul H.
02620eab-ae7f-4a1c-bad1-8a50e7e48951
Lai, Christopher W.
83f3d235-4de6-4462-b3d9-22c377e86afd
Wong, Cesar S.C.
5566017b-ca80-4a87-9d11-4e072e390085
Siu, Parco M.
3a92bd40-810f-44e8-80d3-585b634d0bf6
Yu, Angus P., Ugwu, Felix N., Tam, Bjorn T., Lee, Paul H., Lai, Christopher W., Wong, Cesar S.C. and Siu, Parco M.
(2018)
Ghrelin axis reveals the interacting influence of central obesity and hypertension.
Frontiers in Endocrinology, 9 (9), [534].
(doi:10.3389/fendo.2018.00534).
Abstract
Objective: This study aimed to investigate how central obesity and hypertension modulate unacylated ghrelin (UnAG), acylated ghrelin (AG), obestatin, growth hormone (GH), and the ratios of UnAG/obestatin, AG/obestatin, and total ghrelin/obestatin. Methods: Circulatory abundances of UnAG, AG, obestatin and GH were determined in 387 Hong Kong Chinese female adults with age between 24 to 86 years based on a 2 × 2 factorial design of hypertension (blood pressure ≥140/90 mmHg) and central obesity (waist circumference or WC ≥80 cm). Participants were categorized as neither hypertensive nor centrally obese (NHNO; n = 105), hypertensive but not centrally obese (HNO; n = 102), centrally obese but not hypertensive (NHO; n = 74) and hypertensive and centrally obese (NO; n = 106). Pearson's correlation analyses were performed to detect the association between the peptides examined with WC and blood pressure. The main and interaction effects of hypertension and central obesity were examined by generalized estimating equations analyses. Results: Correlation analyses revealed that systolic blood pressure was negatively correlated with AG/obestatin, UnAG/obestatin and total ghrelin/obestatin ratios, AG, total ghrelin, and GH, while diastolic blood pressure was negatively correlated with UnAG/obestatin, total ghrelin/obestatin ratios, and GH. WC was negatively correlated with AG/obestatin, UnAG/obestatin, and total ghrelin/obestatin ratios, UnAG, AG, total ghrelin, GH, and obestatin. Interaction effects of hypertension and central obesity were observed on UnAG/obestatin, AG/obestatin and total ghrelin/obestatin ratios, and obestatin. Obestatin in NHO group was significantly higher compared to NHNO and HO groups. UnAG/obestatin, AG/obestatin, and total ghrelin/obestatin ratios were higher in NHNO group compared to HNO and HO groups. Main effects of central obesity and hypertension were observed in UnAG, total ghrelin and GH. The HO group manifested the lowest level of UnAG, total ghrelin and GH among all the groups studied. Main effect of hypertension was observed on AG, suggesting that hypertensive individuals exhibited lower levels of AG regardless of central obesity. Conclusion: Circulatory ghrelin gene products and GH exhibit different modes of modulation in response to the co-manifestation of multiple cardiovascular risk factors compared with a single risk factor alone.
This record has no associated files available for download.
More information
Accepted/In Press date: 22 August 2018
Published date: 12 September 2018
Additional Information:
Funding Information:
This study was supported by the University of Hong Kong Seed Fund for Basic Research, Hong Kong Polytechnic University Research Fund (RU3N) and the Hong Kong Jockey Club Charities Trust.
Publisher Copyright:
© 2007 - 2018 Frontiers Media S.A. All Rights Reserved.
Keywords:
Central obesity, Ghrelin, Growth hormone, Hypertension, Obestatin
Identifiers
Local EPrints ID: 475095
URI: http://eprints.soton.ac.uk/id/eprint/475095
ISSN: 1664-2392
PURE UUID: 5c5f7f06-46c8-4f79-9b6c-5c02552b7a06
Catalogue record
Date deposited: 09 Mar 2023 19:08
Last modified: 18 Mar 2024 04:09
Export record
Altmetrics
Contributors
Author:
Angus P. Yu
Author:
Felix N. Ugwu
Author:
Bjorn T. Tam
Author:
Paul H. Lee
Author:
Christopher W. Lai
Author:
Cesar S.C. Wong
Author:
Parco M. Siu
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics